Project Grant R21AA031765
Award Date
9/20/24
Completion Date
8/31/26
Dollars Obligated
$187K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92123, USA
Similar Awards
This federal Project Grant award of $145,642 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a longitudinal study examining the associations between adolescent alcohol and cannabis co-use, socioeconomic status, and state-level cannabis policy. The research project, titled "ADOLESCENT ALCOHOL AND CANNABIS TRANSITIONS: ASSOCIATIONS WITH MULTIDIMENSIONAL SES AND CANNABIS POLICY," aims to identify patterns...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,953,061 to the University of Colorado-Denver to conduct a randomized, double-blind, placebo-controlled clinical trial. The study will investigate whether maternal choline supplementation can mitigate the effects of prenatal cannabis exposure on early brain development and subsequent childhood behavior in 120 pregnant women who use cannabis...
This Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), aims to provide translational research and training to bridge the gap between basic science and clinical interventions for Fetal Alcohol Spectrum Disorders (FASD).
The $405,252 award, with a period of performance from May 1, 2024 to April 30, 2029, will allow the awardee, San Diego State University Research Foundation, to characterize physical...
This Project Grant award from the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $390,635 to the University of Pittsburgh to develop a novel intervention to reduce co-use of tobacco and cannabis among pregnant and postpartum individuals, particularly those from minoritized groups.
The key objectives are to: 1) conduct formative research on the experiences of marginalized pregnant people who use cannabis and tobacco, 2) co-create an...
This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will fund research to investigate the neuroepigenetic mechanisms underlying the transgenerational effects of alcohol exposure.
The $148,568 award will enable the primary grantee, the University of California, Los Angeles (UCLA), to conduct studies using the C. elegans model system to identify the specific neuronal...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) provides $799,271.38 to study parenting behaviors that contribute to improved treatment outcomes for adolescents with alcohol use disorders and co-occurring psychiatric disorders (AUD+COD).
The research, led by Principal Investigator Dr. Samuel Meisel, aims to leverage an experimental medicine framework to understand how parenting, assessed in...
This $197,262 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), aims to investigate how cannabis use affects treatment outcomes for adolescents with alcohol use disorder (AUD) and co-occurring psychiatric disorders (CODs) in community-based treatment settings.
The key objectives are to use qualitative interviews, ecological momentary assessment, and longitudinal surveys to understand the dynamics of how...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $317,534.10 in funding to the University of North Carolina at Chapel Hill to conduct research on maternal-fetal metabolic disruption caused by prenatal alcohol exposure.
The key products and services to be delivered include:
Quantifying maternal-fetal glucose levels, gluconeogenesis, and related metabolite pools to understand how...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to examine the impact of prenatal exposure to cannabis on childhood adiposity and cardiometabolic health outcomes. The $234,000 award to the University of Colorado-Denver will measure levels of delta-9-tetrahydrocannabinol (D9-THC) and cannabidiol (CBD) in maternal and umbilical cord blood samples to test the hypothesis that prenatal cannabis exposure...